Friday 6 November 2026 Export AUPH’s income statement to Excel — free account

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc’s revenue for fiscal 2025 (year ended December 2025) was $283.1 million, up 20.4% from fiscal 2024.

Revenue: +13.9%
EPS: 0.00%
Free cash flow: +4.41%
Total debt: −30.0%

Quarter to September 2026, against a year earlier

16.48 0.27 +1.67%

Follow AUPH

Alert me

Market cap: $2.2B
P/E: 6.8×
Fwd P/E: 17.6×
Dividend yield: —
F-score: 8/9
Altman Z: 7.86
Beneish M: −0.88
Dividend safety: n/a

Overview

Aurinia Pharmaceuticals Inc (AUPH) P/E ratio

Alert me on P/E ratio

As of 5 November 2026, Aurinia Pharmaceuticals Inc (AUPH) trades at a P/E ratio of 6.8×. Over the past ten years it has ranged from 0.0× (December 2024) to 200× (December 2024); the current reading is higher than 88% of that period. That is below the Biotechnology industry median of 10.3× and below the Healthcare sector median of 25.2×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/AUPH/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Aurinia Pharmaceuticals Inc P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/AUPH/metrics/pe-ratio">Aurinia Pharmaceuticals Inc (AUPH) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	7.4×	(96.32%)
FY2024	200×	—
FY2023	0.0×	—
FY2022	0.0×	—
FY2021	0.0×	—
FY2020	0.0×	—
FY2019	0.0×	—
FY2018	0.0×	—
FY2017	0.0×	—
FY2016	0.0×	—

Period	P/E ratio	Change
Sep 2026	6.8×	(4.54%)
Jun 2026	7.1×	8.28%
Mar 2026	6.6×	(10.78%)
Dec 2025	7.4×	(61.42%)
43 more quarters	Free account

Against its own ten years

Low 0.0× High 200×

Ten-year median 0.0×

Current reading's percentile 88

Company	P/E ratio
PVLA Palvella Therapeutics, Inc. compare	n/m
BHVN Biohaven Ltd. compare	n/m
LKFT Lakefront Biotherapeutics - Sponsored ADR compare	n/m
VERA Vera Therapeutics, Inc. compare	n/m
CLDX Celldex Therapeutics, Inc. compare	n/m
IMNM Immunome, Inc. compare	n/m
AUPH Aurinia Pharmaceuticals Inc	6.8×
ADMA ADMA Biologics Inc compare	16.7×
VCEL Vericel Corporation compare	77.8×
Biotechnology industry median	10.3×
Healthcare sector median	25.2×
Market median	17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

Aurinia Pharmaceuticals Inc (AUPH) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on AUPH

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on AUPH

Stockrow Weekly